Everlab Raises A$65M to Build the Infrastructure for Preventive Healthcare

Everlab is bringing diagnostics, clinicians, and continuous care into one connected health platform.

Most healthcare begins after something goes wrong. Symptoms appear, appointments are scheduled, tests are ordered, and information moves between providers that rarely share the full picture.

Led by founders Marc Hermann and Anshul Jain, Everlab is building around a different model: identify risks earlier and make it easier to act on them.

The team raised a A$65 million in Series A funding led by Airtree, with participation from Plural, b2venture, Left Lane Capital, and several angel investors, including Australian cricket captain Pat Cummins.

Everlab combines advanced diagnostic testing with doctors, specialists, prescriptions, wearable data, and AI-supported care through a single platform. Rather than leaving patients to interpret isolated test results, the platform organizes their health information and helps coordinate the screenings, interventions, and follow-up steps that come next.

The company has already analyzed more than 20,000 clients across Australia and New Zealand. The company’s testing has uncovered previously undetected health issues in more than one-quarter of clients.

That is the larger opportunity behind the round. Preventive care is not only about running more tests. It requires an operating layer capable of connecting fragmented health data to meaningful clinical action.

Everlab will use the new capital to expand into the UK and continue building its clinical and technology infrastructure. As healthcare shifts from episodic treatment toward continuous prevention, platforms that can hold the full picture of a person’s health may become an increasingly important part of the system.

Read the full article on the Startup Daily.